EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of Metabolic Phenotypes with Cardiac Structure and Clinical Outcomes: Insights from the UK Biobank

Balázs Bogner iD, Matthias Jung, Marco Reisert, Juliane Maushagen iD, Susanne Rospleszcz iD, Janis M Nolde, Christopher L Schlett iD, Fabian Bamberg iD, Andreas Kammerlander iD, Jakob Weiss, Jana Taron

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Balázs Bogner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg 7910…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Obesity, Cardiovascular Diseases, Heart. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Metabolic syndrome and obesity represent major cardiovascular risk factors, yet their combined effects on cardiac structure and clinical outcomes remain incompletely understood.

Objective

To examine associations between metabolic phenotypes, cardiac magnetic resonance imaging (CMR), and clinical outcomes.

Design

Prospective study with a median 5.1-year follow-up.

Setting

Population-based cohort from the UK Biobank.

Participants

A total of 22 789 participants (mean age 64.1 ± 7.5 years, 52.6% female) were categorized as metabolically healthy nonobese (MHN) vs obese (MHO) or unhealthy nonobese (MUN) vs obese (MUO), based on obesity (body mass index ≥30 kg/m²) and metabolic status (prevalent diabetes or both hypertension and hyperlipidemia). Main Outcome Measure(s) Primary and secondary endpoints were major adverse cardiovascular events (MACE) and all-cause mortality, respectively. CMR included left ventricular ejection fraction (LVEF, %), end-diastolic volume (LVEDV, mL), myocardial mass (g), wall thickness (mm), cardiac output (L/min), and left atrial volume (mL). Linear regression and Cox proportional hazards models, adjusted for age, sex, and smoking, assessed associations between metabolic phenotypes, CMR, and clinical outcomes.

Results

In adjusted models, all phenotypes demonstrated increased WT (MHO: β=.53 [.50, .55]; MUN: β=.24 [.21, .27]; MUO: β=.66 [.61, .70]), compared to MHN. LVEDV was increased in obesity phenotypes (MHO: β=4.67 [4.07, 5.27]; MUO: β=5.14 [4.05, 6.22]) and decreased in MUN (β=−1.25 [−1.95, −.55]), while MUO showed reduced LVEF (β=−.48 [−.91, −.04]). MACE risk was increased in unhealthy phenotypes (MUN: adjusted hazard ratio (aHR) = 1.55 [1.16-2.07]; MUO: aHR = 1.95 [1.28-2.97]). All phenotypes showed increased all-cause mortality risk (MHO: aHR = 1.65 [1.23-2.21]; MUN: aHR = 1.41 [1.05-1.90]; MUO: 2.10 [1.41-3.15]).

Conclusion

Metabolic phenotypes show distinct cardiac structural changes and increased mortality risk, supporting their potential in cardiovascular risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeObesityCardiovascular DiseasesHeartHumansFemaleMaleMiddle AgedUnited KingdomBiological Specimen BanksPhenotypeAgedProspective StudiesMagnetic Resonance ImagingFollow-Up StudiesRisk FactorsUK Biobank

Stichwörter der Autor:innen

cardiovascular diseasesmagnetic resonance imagingmetabolismmortalityobesity

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.
  • Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.
  • Division of Medical Physics, Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.
  • Department of Stereotactic and Functional Neurosurgery, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.
  • Department of Internal Medicine IV (Nephrology), University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.
  • Department of Cardiology, Medical University of Vienna, Vienna General Hospital, Vienna 1090, Austria.

ORCID-Profile: Balázs Bogner, Juliane Maushagen, Susanne Rospleszcz, Christopher L Schlett, Fabian Bamberg, Andreas Kammerlander

Zitieren

APA

Bogner, B., Jung, M., Reisert, M., Maushagen, J., Rospleszcz, S., Nolde, J. M., Schlett, C. L., Bamberg, F., Kammerlander, A., Weiss, J., & Taron, J. (2025). Associations of Metabolic Phenotypes with Cardiac Structure and Clinical Outcomes: Insights from the UK Biobank. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf684

Vancouver

Bogner B, Jung M, Reisert M, Maushagen J, Rospleszcz S, Nolde JM, et al. Associations of Metabolic Phenotypes with Cardiac Structure and Clinical Outcomes: Insights from the UK Biobank. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf684

BibTeX
@article{Bogner2025,
  author = {Bogner, Balázs and Jung, Matthias and Reisert, Marco and Maushagen, Juliane and Rospleszcz, Susanne and Nolde, Janis M and Schlett, Christopher L and Bamberg, Fabian and Kammerlander, Andreas and Weiss, Jakob and Taron, Jana},
  title = {Associations of Metabolic Phenotypes with Cardiac Structure and Clinical Outcomes: Insights from the UK Biobank},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf684}
}
Kostenlos starten →